US Stock MarketDetailed Quotes
NEXI NexImmune
- 3.3700
- -0.0400-1.17%
Close Apr 26 16:00 ET
4.62MMarket Cap-109P/E (TTM)
3.4700High3.3700Low3.39KVolume3.3960Open3.4100Pre Close11.56KTurnover0.33%Turnover RatioLossP/E (Static)1.37MShares28.694952wk High1.32P/B3.47MFloat Cap1.250152wk Low--Dividend TTM1.03MShs Float700.0000Historical High--Div YieldTTM2.93%Amplitude1.2500Historical Low3.4070Avg Price1Lot Size
NexImmune Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.60%-31.43M | 47.57%-5.83M | 38.62%-7.28M | 48.57%-6.03M | 25.44%-12.28M | -11.81%-51.19M | 2.74%-11.12M | -23.90%-11.87M | 13.88%-11.72M | -47.69%-16.48M |
| Net income from continuing operations | 48.25%-32.34M | 68.28%-5.36M | 33.10%-9.85M | 52.29%-7.57M | 36.33%-9.57M | -22.80%-62.51M | -8.81%-16.89M | -0.56%-14.73M | -30.20%-15.86M | -75.78%-15.02M |
| Operating gains losses | 3,080.38%676.28K | 1,024.63%679.97K | ---- | ---- | ---- | 100.65%21.26K | -13,161.99%-73.54K | 110.73%89.66K | ---- | ---- |
| Depreciation and amortization | 3.03%1.02M | -13.47%228.51K | 1.79%265.54K | 10.00%267.16K | 16.22%263.77K | 14.31%994.79K | 8.57%264.09K | 11.88%260.87K | 10.63%242.87K | 30.19%226.96K |
| Other non cash items | 7.36%537.41K | -17.14%106.43K | 32.46%167.16K | 7.31%133.08K | 7.25%130.74K | -44.62%500.55K | --128.44K | --126.19K | 12,401,200.00%124.01K | -86.51%121.9K |
| Change In working capital | -224.15%-4.88M | -152.96%-2.1M | 8.39%1.04M | -94.04%145.96K | -14.82%-3.96M | 500.31%3.93M | 80.09%3.97M | -76.38%955.07K | 178.12%2.45M | -40.10%-3.45M |
| -Change in prepaid assets | 12.96%1.95M | -91.46%265.57K | 206.25%1.21M | -16.77%760.88K | 89.30%-288.69K | 183.92%1.72M | 24.66%3.11M | -72.51%394.84K | 125.83%914.14K | -10.22%-2.7M |
| -Change in payables and accrued expense | -278.58%-4.72M | -173.53%-687.45K | -104.26%-29.43K | -128.67%-475.92K | -451.00%-3.53M | -12.09%2.65M | 9,361.47%934.89K | -73.50%690.94K | 310.66%1.66M | -5,010.27%-640.83K |
| -Change in other current assets | -2,684.86%-1.53M | ---- | ---- | ---- | ---- | 119.66%59.13K | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -15.00%-573.1K | -13.82%-152.92K | -10.58%-144.53K | -10.76%-138.99K | -26.75%-136.65K | ---498.35K | ---134.36K | ---130.71K | ---125.48K | ---107.81K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.60%-31.43M | 47.57%-5.83M | 38.62%-7.28M | 48.57%-6.03M | 25.44%-12.28M | -11.81%-51.19M | 2.74%-11.12M | -23.90%-11.87M | 13.88%-11.72M | -47.69%-16.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.09%-44.49K | 0 | -99.97%3.25K | -100.02%-5.02K | -100.40%-42.72K | 193.51%50.32M | -103.58%-143.16K | 169.42%11.94M | 169.70%27.9M | 1,928.49%10.62M |
| Net PPE purchase and sale | 96.21%-44.49K | --0 | 100.58%3.25K | 95.95%-5.02K | 87.59%-42.72K | 50.04%-1.17M | 72.26%-143.16K | -181.19%-562.73K | 88.22%-124.06K | 40.71%-344.36K |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | 200.06%51.49M | --0 | 173.55%12.5M | 171.90%28.03M | --10.96M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.09%-44.49K | --0 | -99.97%3.25K | -100.02%-5.02K | -100.40%-42.72K | 193.51%50.32M | -103.58%-143.16K | 169.42%11.94M | 169.70%27.9M | 1,928.49%10.62M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | -95.85%5.18M | 0 | 2,314.94%5.15M | 0 | -99.97%33.26K |
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | -95.51%5.15M | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | -97.15%33.26K | --0 | --0 | --0 | -88.86%33.26K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --0 | --0 | -95.85%5.18M | --0 | 2,314.94%5.15M | --0 | -99.97%33.26K |
| Net cash flow | ||||||||||
| Beginning cash position | 14.16%34.7M | -80.30%9.06M | -59.91%16.34M | -8.96%22.37M | 14.16%34.7M | 496.12%30.39M | 23.15%45.97M | -36.21%40.75M | -79.21%24.57M | 496.12%30.39M |
| Current changes in cash | -831.38%-31.47M | 48.24%-5.83M | -239.58%-7.28M | -137.30%-6.03M | -111.70%-12.33M | -82.99%4.3M | -62.60%-11.27M | 119.64%5.22M | 129.80%16.18M | -105.15%-5.82M |
| End cash Position | -90.71%3.22M | -90.71%3.22M | -80.30%9.06M | -59.91%16.34M | -8.96%22.37M | 14.16%34.7M | 14.16%34.7M | 23.15%45.97M | -36.21%40.75M | -79.21%24.57M |
| Free cash flow | 39.98%-31.48M | 48.61%-5.83M | 41.39%-7.29M | 49.07%-6.03M | 26.71%-12.33M | -8.96%-52.45M | 5.06%-11.35M | -27.12%-12.43M | 19.22%-11.85M | -43.31%-16.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg